EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Prognostic Significance and Immune Correlation of CCL3 Expression in Colon Adenocarcinoma: Insights From Multidatabase Analysis

Vikrant Kumar, Nawaid Hussain Khan iD, Shashi Nandar Kumar iD, Neeraj Mahajan iD, Wafa Aziz, Vinay Kumar iD, Chaitenya Verma iD

Biochemistry Research International · 2026-01 · 2026 (1)

DOI: 10.1155/bri/6647501 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Biochemistry Research International, online erschienen am 17.04.2026. Verfasst von Vikrant Kumar und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biophysics, All India Institute of Medical Sciences (AIIMS), New Delhi, 29, India, aiims.edu. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 75 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

Colon adenocarcinoma (COAD) remains a leading cause of cancer‐related mortality, necessitating reliable prognostic biomarkers. This study explored the potential prognostic role of C‐C motif chemokine ligand 3 (CCL3) and its association with immune‐related signatures in COAD.

Methods

Multiple publicly accessible databases, including TCGA, GEPIA2, UALCAN, TIMER, and Kaplan–Meier (KM) plotter, were used to examine the expression and prognostic profiles of CCL3 in various cancers. The association between CCL3 expression and clinical stage, immune infiltration, and immune gene markers was investigated using TIMER, GEPIA2, and TISIDB databases. Furthermore, we conducted functional enrichment analyses (GO and KEGG) of genes coexpressed with CCL3, assessed methylation status using OncoBD and MEXPRESS, and developed a gene–miRNA interaction network using miRWalk to elucidate their potential roles in COAD.

Results

The expression of CCL3 was significantly upregulated in COAD and most other malignancies. Furthermore, high CCL3 expression was significantly associated with poor overall survival (OS) and relapse‐free survival (RFS), with a univariate HR = 1.52 (95% CI: 1.12–2.06, p < 0.01). Multivariate Cox regression confirmed CCL3 as an independent prognostic factor after adjusting for the TNM stage, age, gender, and grade (adjusted HR = 1.42, 95% CI: 1.05–1.92, p = 0.023). CCL3 showed strong positive correlations with immune cell infiltration, particularly macrophages (Cor = 0.72, p < 0.001) and neutrophils (Cor = 0.74, p < 0.001), suggesting its role in shaping an immunosuppressive tumor immune microenvironment (TIME). Additionally, preliminary correlations indicate that high CCL3 may be associated with chemotherapy resistance.

Conclusion

This study suggests that CCL3 could serve as a potential prognostic marker for COAD and other cancers. Because CCL3 expression was strongly associated with immune modulation within the tumor microenvironment, this pointed out that CCL3 could serve as a promising therapeutic target with significant implications for immunotherapy and chemotherapy response.

Schlagwörter

Stichwörter der Autor:innen

CCL3colon adenocarcinomaimmune infiltrationmiRNAprognostic marker

Autor:innen und Institutionen

  • Department of Biophysics, All India Institute of Medical Sciences (AIIMS), New Delhi, 29, India, aiims.edu.
  • Faculty of Medicine, Ala-Too International University, Bishkek, Kyrgyzstan.
  • Department of Occupational and Environmental Health, Faculty of Pharmaceutical Sciences, Tokyo University of Science, Noda, 278-8510, Japan, tus.ac.jp.
  • Department of Microbiology, All India Institute of Medical Sciences (AIIMS), New Delhi, 29, India, aiims.edu.
  • Pennsylvania State University Hershey Medical Center, 500 University Dr, Hershey, Pennsylvania, USA.
  • Department of Biotechnology, School of Engineering and Technology, Sharda University, Grater Noida, India, sharda.ac.in.

ORCID-Profile: Nawaid Hussain Khan, Shashi Nandar Kumar, Neeraj Mahajan, Vinay Kumar, Chaitenya Verma

Zitieren

APA

Kumar, V., Khan, N. H., Kumar, S. N., Mahajan, N., Aziz, W., Kumar, V., & Verma, C. (2026). Prognostic Significance and Immune Correlation of CCL3 Expression in Colon Adenocarcinoma: Insights From Multidatabase Analysis. Biochemistry Research International, 2026(1). https://doi.org/10.1155/bri/6647501

Vancouver

Kumar V, Khan NH, Kumar SN, Mahajan N, Aziz W, Kumar V, et al. Prognostic Significance and Immune Correlation of CCL3 Expression in Colon Adenocarcinoma: Insights From Multidatabase Analysis. Biochemistry Research International. 2026;2026(1). doi:10.1155/bri/6647501

BibTeX
@article{Kumar2026,
  author = {Kumar, Vikrant and Khan, Nawaid Hussain and Kumar, Shashi Nandar and Mahajan, Neeraj and Aziz, Wafa and Kumar, Vinay and Verma, Chaitenya},
  title = {Prognostic Significance and Immune Correlation of CCL3 Expression in Colon Adenocarcinoma: Insights From Multidatabase Analysis},
  journal = {Biochemistry Research International},
  year = {2026},
  volume = {2026},
  number = {1},
  doi = {10.1155/bri/6647501}
}
Kostenlos starten →